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Abstract
Background: Most patients with malaria seek treatment first in retail drug shops. Myriad studies have examined
retailer behaviours and characteristics to understand the determinants to these behaviours. Geospatial methods are
helpful in discovering if geographic location plays a role in the relationship between determinants and outcomes. This
study aimed to discover if spatial autocorrelation exists in the relationship between determinants and retailer behaviours, and to provide specific geographic locations and target behaviours for tailoring future interventions.
Methods: Retailer behaviours and characteristics captured from a survey deployed to medicine retailers in the
Webuye Demographic and Health Surveillance Site were analysed using geographic weighted regression to create
prediction models for three separate outcomes: recommending the first-line anti-malarial therapy to adults, recommending the first-line anti-malarial therapy to children, and selling that therapy more than other anti-malarials. The
estimated regression coefficients for each determinant, as well as the pseudo R2 values for each final model, were
then mapped to assess spatial variability and local areas of best model fit.
Results: The relationships explored were found to be non-stationary, indicating that spatial heterogeneity exist in
the data. The association between having a pharmacy-related health training and recommending the first-line antimalarial treatment to adults was strongest around the peri-urban centre: comparing those with training in pharmacy
to those without training (OR = 5.75, p = 0.021). The association between knowing the first-line anti-malarial and
recommending it to children was strongest in the north of the study area compared to those who did not know the
MOH-recommended anti-malarial (OR = 2.34, p = 0.070). This is also the area with the strongest association between
attending a malaria workshop and selling the MOH-recommended anti-malarial more than other anti-malarials, compared to retailers who did not attend a workshop (OR = 2.38, p = 0.055).
Conclusion: Evidence suggests that spatial heterogeneity exists in these data, indicating that the relationship
between determinants and behaviours varies across space. This is valuable information for intervention design, allowing efforts to focus on those factors that have the strongest relationship with their targeted behaviour within that
geographic space, increasing programme efficiency and cost-effectiveness.
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Background
Malaria is one of the world’s most widespread parasitic diseases, causing an estimated 214 million cases of
disease, and approximately 438,000 deaths in 2015 [1].
The incidence rate in Kenya was 8200 cases per 100,000
population in 2012, with particular burden among
children under the age of 5 years [2]. In Kenya, several
studies have shown that families first seek treatment
for malaria from retail drug shops rather than from
the public health sector [3–5]. However, assessments
of private medicine retailer practice have shown that
retailers often recommend, prescribe, and dispense
outdated or inappropriate treatments for malaria [6–
9]. The Kenya Ministry of Health recommendation for
first-line treatment of uncomplicated malaria changed
from sulfadoxine-pyrimethamine (SP), also known by
the brand name Fansidar®, to artemisinin-based combination therapies therapy (ACT) in 2006. Since that
time, the importance of exploring determinants to
medicine retailer dispensing behaviours has grown, to
ensure providers are adhering to the new policies and
customers are getting access to the more effective treatment [10].
The change in treatment recommendation, combined
with treatment-seeking behaviour in retail drug shops,
spurred the launch of the Affordable Medicines Facility—Malaria (AMFm) programme, which sought to subsidize the cost of ACT in the retail sector to encourage
their sale over other anti-malarials. This effort moved
medicine retailers even closer to the forefront of malaria
treatment and control efforts. As a result, understanding
the determinants of medicine retailer behaviour, and discovering ways to improve their knowledge and practice,
has become the focus of numerous training and education programmes [11–13].
However, interventions are often not as effective as
they could be. Improvements are frequently inconsistent across study sites, showing behaviour improvements
in one area and not in other areas. For example, a Ministry of Health (MoH) intervention assessment by Abuya
and colleagues used a cluster randomized controlled trial
to compare intervention efficacy across three districts in
Kenya [6]. The interventions examined focus on improving anti-malarial knowledge of private medicine retailers.
They found that MoH interventions made considerable
gains in medicine retailer knowledge and practice in the
district of Makueni, made moderate gains in the district
of Kwale, but made fewer gains in the district of Busia.
Another intervention programme [12] made more
improvements in reducing the sales of SP and increasing
the rate of correct anti-malarial dosage in the district of
Kisii than they did in the district of Kwale. The region in
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which these programmes were implemented was related
to their success. Since intervention programmes of this
kind are also costly, recommendations have been made
to increase intervention efficacy by adapting them to the
local context [14, 15], rather than implementing the same
programme across the study area.
Geospatial analysis techniques can be used to meet this
need by helping define the local context. These methods can find the distance between health facilities and
residents [16], demonstrate how this distance affects
treatment-seeking behaviour [17], and show whether
behaviours are clustering in space [18]. These methods
have been used to detect and predict clusters and spatio-temporal trends of malaria disease [19–22], to map
malaria-related treatment and prevention behaviours
[23–25], and have looked at the predictors to accessing
effective malaria treatment within the retail sector [3, 35,
36]. Geospatial methods have also been used to inform
interventions by showing where disease, and behaviours
that relate to disease, are most prevalent [26]. However,
geospatial techniques have infrequently been applied
to improving rates of effective malaria treatment in the
retail sector has been largely unexplored [23–25], and
have not yet been applied with medicine retailers. With
the proven success and continued recommendation
of targeting interventions based on the results of spatial analyses [27, 28], and the multitude of intervention
programmes designed to improve access to appropriate
malaria treatment and implemented in the retail sector
[6, 11–13, 29, 30], applying spatial analysis to medicine
retailers’ anti-malarial behaviours presents an opportunity to support malaria eradication efforts.
The World Health Organization (WHO) has promulgated leveraging geospatial analysis techniques for
malaria control and eradication. Senior advisors have
published a call to use these techniques to support
targeted interventions in malaria control, to lead to
increases in cost-effectiveness, and intervention-effectiveness [26]. With the increase in attention medicine
retailers are receiving as a result of programmes like
AMFm, and the need to reduce costs by developing spatially- and behaviourally-targeted interventions, studies
on the geospatial variation in medicine retailer behaviours are needed.
It is the objective of this research to identify determinants to medicine retailer recommendation and dispensation behaviours and to assess whether the strength of
those associations varies across the study area. Understanding where each determinant is significantly related
to medicine retailer behaviours will enable interventions
to target these areas, advancing malaria treatment and
control efforts in the region.
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Methods
Study area and sample

O’Meara and colleagues conducted a quantitative survey
of private medicine retailers working in retail drug shops
located within, or up to five kilometers from, the Webuye
Health and Demographic Surveillance Site (WHDSS) [8,
16, 31]. The WHDSS is in the Bungoma district of western Kenya (Fig. 1). The study area is home to approximately 80,000 persons and has a primary economy of
subsistence farming and that provided by a local sugarprocessing factory [32]. The area is holo-endemic for
malaria, with over 40% of a random sample of the people
living in the Western Province having Plasmodium falciparum parasites in their peripheral blood [33].
Data collection

Study staff were each assigned to cover a sub-section of
the study area by motorbike. Staff visited every medicine
retailer in their area in December of 2010, recording the
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name and GPS coordinates of each location. A quantitative survey tool was administered to one medicine
retailer at each drug outlet location that met the inclusion criteria. Inclusion criteria were comprised of carrying anti-malarial medications and businesses that were
privately owned. Exclusion criteria included locations
that only sold general goods and sundries, were public
health facilities, or refused participation. Further detail
of data collection methods has been published elsewhere
[16].
Measures

The survey tool included eighty questions. Of the variables measured related to participant demographics, this
analysis included respondent’s age, which was captured
categorically and collapsed to the following categories:
under 30, between 30 and 40, and over 40. Respondent’s
education level was also included, which was captured
in five categories (“none,” “some primary,” “completed

Fig. 1 Map of Kenya, with the Bungoma district containing the study area inset
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primary,” “completed secondary,” and “some or competed
above secondary”) and was collapsed into two categories,
combining the upper two categories and the lower three
categories. Respondent’s gender was also included in this
analysis.
Factors related to health training included their type
of health training, which was categorized as being
untrained, having a training in pharmacy (including
pharmacists, pharmacy technologists, and pharmacy
assistants), or having a training in nursing/midwifery
(including nurses, nurse aids, and midwives). Health
qualification level was also included, which was categorized into no training, an assistant-level training,
or a professional-level training. The binary variable of
whether the respondent had ever attended a malaria
workshop was also included. Variables related to characteristics of the drug shop included whether the shop
offered diagnostic testing services, was open on weekends, was open more than 10 h a day or fewer than 10 h
a day, and whether the shop had 1 staff member, 2 staff
members, or 3-6 staff members.
The first outcome variable included in this analysis was
whether a shop sold ACT medicines more than any other
anti-malarial. This outcome was measured with the question, “Even if it is currently out of stock, which malaria
medicine is most sold in your shop?” Responses were
open-ended, and were coded either to ACT treatments,
or to responses that included reference to any other antimalarial therapy.
The second outcome analysed was which medication
a medicine retailer would recommend to an adult with
malaria. This outcome was measured with the question,
“Which malaria medicine do you recommend most for
adults.” Responses were coded in the same manner as the
above question on anti-malarial drug knowledge, into
“ACT” and “Not ACT” categories.
The third outcome analysed was which medication
a retailer would recommend for a child under five with
malaria. This outcome was measured with the question,
“Which malaria medicine do you recommend most for
children under 5 years of age.” Responses were coded in
the same manner as the above two outcomes.
All of the above variables were selected for analysis
based on a review of the literature, with weight given to
the findings from studies conducted in the WHDSS [16,
31, 34–36].
Data entry and analysis

All data collected from the survey were double entered
into a Microsoft Access database and confirmed. Discrepancies were resolved by consulting the original survey forms. Variables from the survey that are of interest
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in this study were transposed to a binary format, coded
and imported into Stata v11 [37]. All of the above variables were assessed using cluster analysis and found to
have statistically significant spatial clusters. The results
of this cluster analysis have been reported separately [18].
Model building

Model building began with spatial cluster exploration of
each variable considered for entry into the geographic
spatial regression model. The results from this exploration have been reported separately [18]. Those variables
that showed clustering in the exploratory spatial analysis
were compared to each outcome using univariate logistic
regression.
Spatial analysis

Each of the statistically significant associations from the
univariate analysis were included in pairwise comparisons
of nested models. Those additions that improved goodness of fit measures were included in the final regression
model for each variable. The global Moran’s I measure [38]
was run on the residuals to detect spatial autocorrelation,
using GeoDa v1.6 [39]. Geographic weighted regression
(GWR) [40] was run on all three outcomes to investigate
the potential for non-stationary relationships, or relationships that vary across space, between each outcome and
the variables included in the final models, using GWR4
[41]. Geographically-weighted regression produces two
models, a global regression model that assumes relationships are spatially stationary, occurring evenly across the
study area, and a locally varying model that estimates
local local-weighted regression for each point and its
nearer neighbours. Resulting local parameter estimates
are specific to each location. A GWR logistic model for
binary data with an adaptive bi-square geographic kernel
was used. The “golden section search” method was used to
select the optimal bandwidth [41].
Comparisons of global and local models, and assessments of goodness of fit, were made using classic and
corrected Akaike’s Information Criteria (AIC), according
to its intended use with logistic regression models and
the GWR4 software package [40, 42, 43], and deviance
values [44]. The estimated regression coefficients from
the local model were exported and mapped in ArcMap
v.10.1 [45] to assess spatial variability in the coefficients.
The pseudo R2 values for each model were also exported
and mapped to assess local areas where the final models
had the best fit. Finally, the residuals from the three GWR
models were exported and analysed for spatial autocorrelation using Moran’s I, to ensure there was no residual
spatial autocorrelation following the local geographic
weighted regression.

Rusk et al. Malar J (2016) 15:562
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Ethics, consent, and permissions

The study that administered the survey received ethical
review board approval from the Duke University Institutional Review Board in Durham, North Carolina, and the
Moi University Institutional Research and Ethics Committee in Eldoret, Kenya. The study conducting the analysis received approval from the University of Texas Health
Science Center at Houston Committee for the Protection
of Human Subjects, and was assigned IRB protocol number HSC-SPH-14-1035.
The researchers conducting the original study, from
which survey data was analyzed in this study, held meetings with key members of the community, including
village elders, community chiefs, and assistant chiefs
to discuss the objectives of the survey and garner their
approval. Key leaders shared survey objectives with their
communities. Each participant in the survey gave verbal
consent prior to the start of the survey.

Results
The original mapping exercise identified 117 retailers
located within or accessible to the WHDSS. Surveys
were completed from ninety-seven unique shop locations. Of these, six either did not include GIS coordinates of the shop location (n = 4), or recorded the
coordinates incorrectly (n = 2), and were excluded
from this analysis. A map of the study area, showing
shop locations, is available in Fig. 2. Because GWR4
cannot run analyses on missing data, those surveys
that had missing observations for any of the variables
included in the analyses were dropped (n = 4). The final
analysis included 74% of the retailers located within or
accessible to the WHDSS. Of the eighty-seven surveys
that were included, 77% were completed by females,
44% were between the ages of 30 and 40 years, 68%
had above a secondary school education, and 86% had
health-related training. The 10 observations excluded
from the analysis had no significant differences from
those included, and had similar demographics. Of those
excluded, 58% were female, 50% were between 30 and
40 years old, 75% had above a secondary education, and
83% had health-related training.
Results from univariate logistic regression

Each variable that showed statistically significant clustering in the spatial cluster analysis was compared to
each outcome using univariate logistic regression. Those
comparisons were considered significant, and so eligible for entry into the multivariate geographic weighted
regression model, at the p < 0.2 level. The results of
the univariate regression are listed below, separated by
outcome.

Fig. 2 Map of the WHDSS study area showing shop locations,
adapted from Rusk et al. [18]

Recommending correct treatment to adults

Of the medicine retailer demographic variables, only two
were found to have a statistically significant relationship
with the outcome of recommending ACT to treat malaria
in adults. These two include the level of health qualification and the type of health qualification. The associations
of all demographic variables with recommending correct
malaria treatment to adults are described in Table 1.
The odds of recommending correct treatment to adults
increased with the level of health qualification. Assistants were three times more likely to recommend ACT to
treat malaria in adults than those without health-related
training (OR = 3.0, 95% CI 0.67–14.15; p = 0.165), while
professionals were five times more likely to recommend
appropriate treatment (OR = 5.37, 95% CI 1.29–22.26;
p = 0.021). Health-qualification type was also associated
with recommending the correct anti-malarial to adults.
Those trained in pharmacy were five times more likely
to recommend ACT to adults (OR = 5.75, 95% CI 1.31–
25.29; p = 0.021) compared to those without healthrelated training. Those trained in nursing or midwifery
were also more likely to recommend correct treatment
(OR = 3.67, 95% CI 0.86–15.59; p = 0.079) than those
without training.

Rusk et al. Malar J (2016) 15:562
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Table 1 Association between medicine retailer demographics and study outcomes
% (n)

Unadjusted odds ratios and (95% confidence intervals; p values)
Recommended ACTs as malaria
treatment for adult patients

Recommended ACTs as malaria
treatment for under 5 patients

Reported selling ACTs more
than any other antimalarial

Age
Under 30

38% (33)

1 (reference)

1 (reference)

1 (reference)

Between 30 and 40

44% (38)

0.65 (0.25–1.67; 0.371)

1.08 (0.42–2.75; 0.872)

0.99 (0.38–2.54; 0.978)

Over 40

17% (15)

0.98 (0.28–3.39; 0.968)

0.80 (0.23–2.76; 0.724)

0.90 (0.26–3.13; 0.875)

Gender
Female

77% (67)

1 (reference)

1 (reference)

1 (reference)

Male

23% (20)

1.7 (0.60–4.79; 0.317)

0.59 (0.21–1.66; 0.317)

0.93 (0.34–2.57; 0.887)

Education level
Secondary or below

32% (28)

1 (reference)

1 (reference)

1 (reference)

Above secondary

68% (59)

1.1 (0.45–2.71; 0.836)

1.4 (0.56–3.48; 0.475)

1.42 (0.56–3.59; 0.461)

Health qualification type
Untrained

14% (12)

1 (reference)

1 (reference)

1 (reference)

Pharmacy

40% (35)

5.75 (1.31–25.29; 0.021)**

1.5 (0.38–5.93; 0.563)

5.29 (1.01–27.75; 0.049)**

Nurse/midwife

46% (40)

3.67 (0.86–15.59; 0.079)*

2 (0.52–7.72; 0.315)

3.33 (0.64–17.26; 0.151)*

Health qualification level
Untrained

14% (12)

1 (reference)

1 (reference)

1 (reference)

Assistant level

25% (22)

3.0 (0.67–14.15; 0.165)*

2.4 (0.55–10.38; 0.241)*

5 (0.88–28.29; 0.07)*

Professional level

61% (53)

5.37 (1.29–22.26; 0.021)**

1.53 (0.41–5.73; 0.525)

3.83 (0.76–19.22; 0.102)*

Attended malaria workshop
No

59% (51)

1 (reference)

1 (reference)

1 (reference)

Yes

41% (35)

1.63 (0.68–3.92; 0.277)

1.64 (0.69–3.91; 0.264)

2.38 (0.98–5.75; 0.055)*

* Significant at p < 0.2
** Significant at p < 0.05

Table 2 depicts the relationships between medicine
retailer knowledge and behaviours with the outcome of
recommending ACT to treat malaria in adults. Correctly
identifying ACT as the MoH-recommended first-line
treatment for malaria increased the likelihood of recommending that treatment to adults compared to those
who did not correctly identify the recommended malaria
therapy (OR = 3.0, 95% CI 1.21–7.47; p = 0.018). Selling ACT medicines more than any other anti-malarial
also increased the likelihood of recommending it to
adults compared to retailers who did not sell ACT medicines more than other anti-malarials (OR = 8.89, 95% CI
3.11–25.39; p < 0.001). Recommending ACT to children
was also statistically significantly associated with recommending it to adults (OR = 5.37, 95% CI 2.08–13.87;
p = 0.001) compared to retailers who did not recommend ACT to children.
All of the retail drug shop characteristic variables had
statistically significant relationships with recommending ACT to adults. Shops that offered diagnostic testing increased the likelihood three-fold that the retailer
working in that shop recommended ACT to adults
(OR = 3.16, 95% CI 0.62–16.17; p = 0.167), compared to

shops that did not offer testing. These odds also increased
with each additional staff member working in the shop.
Shops with two staff members were almost two times
more likely to recommend ACT than shops with one staff
member (OR = 1.94, 95% CI 0.76–5.0; p = 0.168). Shops
with between three and six staff members were five times
more likely to recommend ACT than shops with one staff
member (OR = 5.4, 95% CI 0.59–49.47; p = 0.136). All
shop level characteristics and their association with recommending correct treatment to adults can be found in
Table 3.
Recommending correct treatment to children

The only medicine retailer demographic variable that had
a statistically significant relationship with recommending ACT to treat malaria in children was having a healthrelated qualification at the assistant level (OR = 2.4, 95%
CI 0.55–10.38; p = 0.241) when compared to untrained
staff, but not at the professional level. However, all of the
retailer knowledge and behaviour variables had statistically
significant relationships with recommending the correct
anti-malarial to children (Table 2). Retailers who identified
the MoH-recommended anti-malarial drug, compared

Rusk et al. Malar J (2016) 15:562
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Table 2 Association between medicine retailer knowledge, behaviours and study outcomes
% (n)

Unadjusted odds ratios and (95% confidence intervals; p-values)
Recommended ACTs as malaria
treatment for adult patients

Recommended ACTs as malaria
treatment for under 5 patients

Reported selling ACTs more
than any other antimalarial

Identified ACT as MOH-recommended antimalarial
No

37% (32)

1 (reference)

1 (reference)

1 (reference)

Yes

63% (55)

3.0 (1.21–7.47; 0.018)**

2.34 (0.93–5.88; 0.070)*

2.36 (0.92–6.03; 0.073)*

Recommended ACT to adults
No

45% (39)

–

1 (reference)

1 (reference)

Yes

55% (48)

–

5.37 (2.08–13.87; 0.001)**

8.89 (3.11–25.39; < 0.001)**

Recommended ACT to children
No

55% (48)

1 (reference)

–

1 (reference)

Yes

45% (39)

5.37 (2.08–13.87; 0.001)**

–

3.76 (1.52–9.28; 0.004)**

Sold ACTs more than any other antimalarial
No

59% (51)

1 (reference)

1 (reference)

–

Yes

41% (36)

8.89 (3.11–25.39; < 0.001)**

3.76 (1.52–9.28; 0.004)**

–

Gave Fansidar to a mother requesting it
No

81% (70)

1 (reference)

1 (reference)

1 (reference)

Yes

18% (16)

0.67 (0.21–2.01; 0.461)

0.36 (0.11–1.25; 0.109)*

0.94 (0.30–2.94; 0.919)

* Significant at p < 0.2
** Significant at p < 0.05

Table 3 Association of retail drug shop characteristics and study outcomes
% (n)

Unadjusted odds ratios and (95% confidence intervals; p values)
Recommended ACTs as malaria
treatment for adult patients

Recommended ACTs as malaria
treatment for under 5 patients

Reported selling ACTs more
than any other antimalarial

Offers diagnostic testing
No

90% (78)

1 (reference)

1 (reference)

1 (reference)

Yes

10% (9)

3.16 (0.62–16.17; 0.167)*

0.58 (0.14–2.5; 0.468)

1.15 (0.29–4.62; 0.844)

Only 1 staff member

60% (52)

1 (reference)

1 (reference)

1 (reference)

2 staff members

32% (28)

1.94 (0.76–5; 0.168)*

1.48 (0.59–3.72; 0.409)

1.74 (0.68–4.41; 0.245)*

3–6 staff members

7% (6)

5.4 (0.59–49.47; 0.136)*

2.95 (0.5–17.6; 0.235)*

1.74 (0.32–9.48; 0.524)

Close weekends

17% (15)

1 (reference)

1 (reference)

1 (reference)

Open weekends

83% (72)

2.1 (0.68–6.53; 0.2)*

1.27 (0.41–3.94; 0.68)

2.2 (0.64–7.57; 0.211)*

Fewer than 10 h

60% (52)

1 (reference)

1 (reference)

1 (reference)

10 or more hours

39% (34)

1.83 (0.75–4.46; 0.181)*

0.51 (0.21–1.23; 0.132)*

1.74 (0.72–4.18; 0.218)*

Total number of staff

Open weekends

Open hours per day

* Significant at p < 0.2
** Significant at p < 0.05

to those who did not, were twice as likely to recommend
it to children (OR = 2.34, 95% CI 0.93–5.88; p = 0.070),
and those who recommended ACTs to adults were five
times as likely to recommend it to children (OR = 5.37,
95% CI 2.08–13.87; p = 0.001) compared to those who
did not recommend ACT to adults. Selling ACT medicines more than any other anti-malarial also increased the
odds of recommending it to children (OR = 3.76, 95% CI

1.52–9.28; p = 0.004). Contrastingly, retailers who would
sell Fansidar® to a mother requesting the drug by name
for her three year old child she believes has malaria were
less likely to recommend an ACT to treat malaria in a child
(OR = 0.36, 95% CI 0.11–1.25; p = 0.109) compared to
retailers who would not sell Fansidar®.
Like recommending correct treatment to adults, the
total number of staff working in a shop was also related

Rusk et al. Malar J (2016) 15:562

to recommending correct treatment to children (Table 3).
Shops with between 3 and 6 staff members were more
likely to recommend ACT than shops with only one staff
member (OR = 2.95, 95% CI 0.5–17.6; p = 0.235). However, retailers working in shops with longer open hours
were less likely to recommend appropriate anti-malarials
to children than shops open fewer than ten hours a day
(OR = 0.51, 95% CI 0.21–1.23; p = 0.132).
Selling ACT medicines more than any other anti‑malarial

Health-qualification type and level were both related to
medicine retailers selling ACT medicines more than any
other anti-malarial (Table 1). Having training in pharmacy or having an assistant level training increased
this likelihood five times (OR = 5.29, 95% CI 1.01–
27.75; p = 0.049) and (OR = 5.0, 95% CI 0.88–28.29;
p = 0.07), respectively, when compared to untrained
staff. Similarly, having training in nursing/midwifery or
at the professional level increased this likelihood by three
times (OR = 3.33, 95% CI 0.64–17.26; p = 0.151) and
(OR = 3.83, 95% CI 0.76–19.22; p = 0.102), respectively,
when compared to untrained staff.
Recommending ACT to adults and to children were
both related to selling ACT medicines more than any
other anti-malarial (Table 2). However, retailers who
identified ACT as the MoH-recommended treatment
for malaria were also more likely to sell ACT medicines
more than other anti-malarial drugs (OR = 2.36, 95% CI
0.92–6.03; p = 0.073) compared to retailers who did not
correctly identify the MoH-recommended anti-malarial.
Retailers who worked in shops that were open weekends,
had two staff members, or were open more than 10 h per
day were also more likely to sell more ACT medicines,
but these relationships were not included in the spatial
analysis because they did not meet the statistical significance levels set a priori (Table 3).
Results from spatial analysis

The determinants included after pairwise comparison for
the outcome of recommending the correct treatment to
adults were recommending that treatment to children,
selling that treatment more than other anti-malarial
therapies, identifying that treatment as the MoH firstline recommendation, and having health-related training.
Determinants included in the final model for recommending ACT to children include recommending it to
adults, selling it more than other anti-malarials, identifying it as the MoH recommending recommended treatment, giving Fansidar® to a mother requesting it, offering
diagnostic testing, and gender. Though gender was not
found to be statistically significantly associated with
treating children appropriately, it was retained in the
final model due to evidence in past research that indicate
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female retailers are more likely to recommend and dispense appropriate treatment to children than male retailers [8]. For the outcome of selling ACT medicines more
than other therapies, the determinants included in the
final model were recommending to adults, to children,
identifying ACT as the first-line anti-malarial drug and
having attended a malaria workshop.
Multivariate logistic regression was run on each final
model, and the residuals were predicted from that model
for each outcome. The global Moran’s I measure was used
to detect the presence of spatial autocorrelation in each
model. The residuals from the final logistic model for
the outcome of recommending the correct treatment to
adult patients revealed spatial autocorrelation (Moran’s
I = 0.10, z = 1.66, pseudo p = 0.048). For the outcome
of recommending the correct treatment to children, the
Moran’s I did not reject the null hypothesis of no spatial autocorrelation (Moran’s I = 0.05, z = 0.88, pseudo
p = 0.178). The residuals from the final model for selling
ACT medicines more than any other anti-malarial also
had spatial autocorrelation (Moran’s I = 0.13, z = 2.06,
pseudo p = 0.027).
Geographic weighted regression was run on all three
models to investigate whether relationships between the
outcome behaviour and the determinants varied across
space. The local parameter estimates for each model are
summarized in Tables 4, 5 and 6. In these tables, statistical significance indicates that those variables vary locally,
within the study area. Those variables that are not statistically significant are not varying locally, but rather are
fixed globally across the study area.
In the outcome of recommending ACTs to treat malaria
in adults, the factors selling ACTs more than other antimalarials and recommending ACTs to children have local
variation, indicating that the relationship between these
variables and the outcome is spatial (Table 4). In the outcome of recommending ACTs to children, the factors

Table 4 Parameter estimates from the geographically
geographically-weighted global regression model for the
outcome of recommending the correct malaria treatment
to adults
Estimate Standard error
Intercept
Identified ACT as MOH-recommended
antimalarial
Recommended correct treatment to children under 5

−2.331

0.88*

0.645

0.559

1.307

0.544*

Had health-related training

1.052

0.865

Sold ACTs more than any other antimalarial

1.787

0.566*

* Denotes statistical significance
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Table 5 Parameter estimates from the geographically
geographically-weighted global regression model for the
outcome of recommending the correct malaria treatment
to children under five
Estimate Standard error
Intercept
Identified ACT as MOH-recommended
antimalarial
Recommended correct treatment to adults
Gave Fansidar to a mother requesting it
Sold ACTs more than any other antimalarial
Female

−1.354
0.602

1.411
−0.982
0.825

−0.89

97.85

91.47

Corrected akaike information criterion

98.58

92.47

0.54

Deviance

87.85

79.78

0.562*
0.685
0.545
0.621

Estimate Standard error

Recommended correct treatment to children under 5

−2.407

Recommended correct treatment to adults
Akaike information criterion

Table 6 Parameter estimates from the geographically geographically-weighted global regression model for the outcome of selling ACT medicines more than any other antimalarial

Intercept

Global model Local model

0.522*

* Statistical significance

Identified ACT as MOH-recommended
antimalarial

Table 7 Comparison of global and local Logistic model
diagnostics for each outcome

0.615*

0.448

0.561

0.742

0.533

Recommended correct treatment to adults

1.8

0.58*

Attended malaria workshop

0.781

0.521

* Statistical significance

recommending that treatment to adults is the only variable with local variation (Table 5). For the outcome of
selling ACTs more than any other anti-malarial, only the
factor recommending that treatment to adults had local
variation (Table 6).
All variables included in the global model were also
tested in the local model. Comparison of AIC values and
deviance values for each outcome are summarized in
Table 7. These comparisons indicate that the local model
was a better fit than the global model for both the recommending correct treatment to adults outcome and the
recommending correct treatment to children outcome.
Using the standard expected decrease of the AIC by 3
points to constitute better fit [40], the outcome of selling
ACT medicines more than any other anti-malarial model
was not a better fit with the local model, indicating that
the relationships in this model were spatially stationary
across the study area and a global spatial model is appropriate. However, both the recommends correct treatment
to adults and recommends correct treatment to children
outcome models have lower AIC, AICc, and deviance
values, indicating that the local model is a better fit for
the data, and that spatial heterogeneity exists in the data.

Recommended correct treatment to children under 5
Akaike information criterion

106.95

99.07

Corrected akaike information criterion

108.01

101.33

94.95

81.49

Deviance

Sold ACTs more than any other antimalarial
Akaike information criterion

101.28

100.75

Corrected akaike information criterion

102.03

102.04

91.28

87.48

Deviance

Model performance was also explored visually in the
data by mapping the local coefficient estimates of the
significant predictor variables from the local models of
each outcome, with the darker the circle indicating the
stronger the association (Figs. 3, 4 and 5).
These visualizations reveal that the association between
having training in a health-related field and recommending the correct anti-malarial treatment to adults is
strongest in the peri-urban centre of Webuye Town and
those locations to the southwest of that centre. In contrast, identifying the correct MoH-recommended antimalarial treatment, and recommending that treatment
to children, have weak associations near the peri-urban
centre, with the strongest associations to the north of the
study area.
The association between having attended a malaria
workshop and selling ACT medicines more than any
other anti-malarial is also strongest in the north of the
study area. The association between giving Fansidar® to
a mother who requests it and recommending the correct anti-malarial treatment to children has the strongest associations due west of the peri-urban centre, in the
southwest of the study area.
The spatial distribution of the pseudo-R2 values
across the study area indicates that the included variables (shown in Tables 1, 2 and 3) have stronger associations with the outcome where the darkest dots are seen,
compared to elsewhere in the study area. The models
for the outcomes of recommending correct treatment
to adults and to children have the best model fit in
the northern part of the study area (see parts 1 and 2
of Fig. 6). Comparatively, the outcome of selling ACT
medicines more than any other anti-malarial has the
best model fit to the west of the peri-urban centre (see
part 3 of Fig. 6).
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Fig. 3 Local coefficient estimates for the statistically significant determinants to the outcome recommending correct antimalarial treatment to
adults, across the Webuye Demographic Health Surveillance Site study area. Panel 1 shows the local coefficient estimates for the statistically significant determinant recommending the correct antimalarial treatment to children under 5 Panel 2 shows the local coefficient estimates for the statistically significant determinant having health-related training Panel 3 shows the local coefficient estimates for the statistically significant determinant
correctly identifying ACTs as the MOH-recommended first-line treatment for uncomplicated malaria The darker the circle indicates the stronger the
association

The residuals of the geographic weighted regression model were tested for spatial autocorrelation using
Global Moran’s I. All outcome models yielded nonsignificant Moran’s I: recommending correct treatment for adults (Moran’s I = −0.09, z = −1.11, pseudo
p = 0.13), for children (Moran’s I = −0.1, z = −1.34,
pseudo p = 0.08), and selling ACT medicines more
than any other anti-malarial outcome: Moran’s I = 0.02,
z = 0.37, pseudo p = 0.33. These results indicate that the
geographic weighted logistic regression was successful
in addressing the spatial autocorrelation existent in the
data.

Discussion
These analyses detected two spatial areas of interest
to malaria control efforts. The first, to the west of the
study region in an area called Bokoli, showed a spatial
relationship between a mother demanding Fansidar®
for her child and a provider recommending appropriate treatment to a child with malaria. This relationship
coincides in space with a previous finding that a greater
number of nursing-trained providers, compared to
pharmacy-trained providers, worked in this area over
what was expected [18]. It could be that, in this area,
far from the peri-urban centre, the district hospital, and

the concentration of pharmacy-trained staff working in
shops, nursing-trained staff are more likely to yield to a
mother’s demands when dispensing anti-malarial medication. Additional research is required to discover what is
unique to the Bokoli area that resulted in these findings.
The second area of interest was in the north of the
study area, in an area known as Misikhu, where the relationships between attending a malaria workshop was
spatially correlated with selling ACT more than another
anti-malarial, and between knowing the MOH-recommended anti-malarial was spatially correlated with recommending that drug to adults. This not only reveals
notable spatial heterogeneity in these relationships,
indicating that geography is important when understanding medicine retailer behaviours, but also a spatial
phenomenon that is occurring in the north of the study
area. This study concurs with previous studies that found
inconsistencies in medicine retailer behaviour across
administrative boundaries [6, 12] in that the shops in this
part of the study region lie outside the boundaries of the
WHDSS. Given that multiple behaviours are converging
in this area, it is a prime target for interventions focused
on improving medicine retailer behaviours for malaria
treatment and control. These findings are also important
when considering the impact political boundaries have
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Fig. 4 Local coefficient estimates for the statistically significant determinants to the outcome recommending correct antimalarial treatment to
children under 5, across the Webuye Demographic Health Surveillance Site study area. Panel 1 shows the local coefficient estimates for the statistically significant determinant recommending correct treatment to adults Panel 2 shows the local coefficient estimates for the statistically significant
determinant giving Fansidar® to a mother requesting it The darker the circle indicates the stronger the association

on health outcomes and behaviours, as they often dictate
where funds are spent and where intervention efforts are
focused.
These analyses demonstrate that traditional aspatial
regression analyses do not completely capture the relationship between retail provider characteristics and
their drug dispensing behaviours. This study also reveals
that spatial correlation between malaria case management behaviours and provider knowledge, training, and
recommending behaviours are behaviour-dependent as
well as space-dependent. In other words, a one-size-fits
all approach to intervening with the hopes of changing
malaria case management behaviours in this study area
would likely be less successful than a customized, tailored
approach that would address the specific behaviours
and outcomes that are most related in that specific subregion. These findings provide support to the recommendations of Carter et al. [26], that national malaria control
programmes begin to incorporate spatial targeting of
their interventions.

From the multivariate geographic weighted regression,
statistically significant relationships were found between
selling ACT medicines more than other anti-malarials,
and recommending ACT to adults. Unexpectedly, statistically significant spatial relationships were not found
between provider training or education and recommendation behaviour, indicating that interventions in this
area should focus on the provider-customer relationship,
over the traditional provider education interventions.
Statistically significant spatial relationships were also
found between recommending ACT to children under
five and recommending ACT to adults. However, significant spatial relationships were not found between recommendation behaviour to children and provider gender, as
had been previously postulated [8]. Past studies on this
population have found significant relationships between
provider behaviour and gender, but when considered in
the light of the spatial analyses, it can be suggested that
these relationships are not spatial. Rather, the relationships between recommendation behaviours are spatial.
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of provider behaviours can provide targets for similar
interventions.
As the data in this study were collected from selfreports, and were not directly observed by study staff,
they are vulnerable to reporting bias. Interviewers did
not request copies of training credentials or professional
licenses to verify participant responses on health training, qualification, or workshop attendance. However,
self-report is more likely to favor a higher or better training than a lesser, indicating that the true effect on study
outcomes may be understated. The outcome of ACT sales
was also self-reported and may be vulnerable to recall
bias, as shop sales data were not analysed in this study.
This outcome is also dependent on anti-malarial stocks,
and as such, sensitive to drug stockouts. However, previous data analysis determine that ACT (in this case, AL),
were not more likely to have been out of stock than other
anti-malarials including SP, amodiaquine, or quinine,
within the last month or on the day of the survey [16].
Generalizability of study findings may be limited due
to the restricted geographic area studied. However, for
those geographic areas that have a similar malaria endemicity profile, with a shared reliance on the retail sector
for malaria case management, these findings could be
meaningful, particularly as it relates to the application of
geospatial analyses to understanding retailer behaviour.
Fig. 5 Local coefficient estimates for the statistically significant determinant to the outcome selling ACTs more than any other antimalarial
medication, across the Webuye Demographic Health Surveillance
Site study area. Panel 1 shows the local coefficient estimates for the
only statistically significant determinant: having attended a malaria
workshop The darker the circle indicates the stronger the association

Interventions hoping to improve provider recommendation, and with it, dispensation behaviour, should consider
that recommendation behaviour is spatially associated
(both with adults and with children). A potential explanation for this is that these behaviours are learned from
retailers working in proximity to one another, where the
relationship between gender and behaviour are not due to
proximity. This discovery supports the train-the-trainer
approaches in interventions. This finding supports those
by Tavrow and colleagues [13], who evaluated a trainthe-trainer programme among medicine retailers in the
same district of Western Kenya. They found that training
mobile vendors and wholesale counter attendants, who
then in turn trained providers in retail outlets, resulted in
improvements in malaria drug knowledge, stocking patterns, and prescribing practices in retail drug shops. This
intervention was also found to be cost effective given its
investment and impact. Leveraging geospatial analyses

Conclusion
The results of this study demonstrate how spatial analysis can provide valuable information for interventions,
revealing where interventions are most needed, and
where the relationship between determinants and target
behaviours are strongest. This information tells interventionists not only where to focus efforts, but it supports
the prioritizing of intervention activities by concentrating on those behaviours most strongly associated with
the outcome of interest. To effectively address low rates
of appropriate malaria case management beliefs and
behaviours, policymakers are advised to consider the
context-specific determinants to these behaviours. These
findings are also useful when choosing where and how to
spend malaria control funds, in that it highlights the need
for intervention in specific spatial areas.
Spatial analyses have been incorporated into national
malaria control programmes to predict malaria risk and
examine the distribution of malarial incidence across tie
and space. These activities have supported the effective
targeting of malaria infection clusters. However, the role
of spatial analysis in malaria eradication has not yet been
expanded to the spatial distribution of behaviours related
to malaria control. Given the interest in effectively managing budgets allocated to malaria intervention, the
role of behaviour in effective malaria control, and the
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Fig. 6 Spatial distribution of pseudo-R2 values for the full model of each outcome, across the Webuye Demographic Health Surveillance Site study
area. Panel 1 shows the spatial distribution of pseudo-R2 values for the full model of the outcome recommending correct treatment to adults Panel
2 shows the spatial distribution of pseudo-R2 values for the full model of the outcome recommending correct treatment to children under 5 Panel
3 shows the spatial distribution of pseudo-R2 values for the full model of the outcome selling ACTs more than another antimalarial The darker the
circle indicates the better the model fit

necessity of supporting treatment and control efforts as
efficiently as possible, geospatial analysis of behavioural
determinants offers a promising advancement toward
eradication efforts.
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